¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦74Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1) : 2022-10-05

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦74Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1) : 2022-10-05
±³À°ÀÏÀÚ : 2022-10-05
±³À°Àå¼Ò : ¼­¿ï COEX Room C ¿Ü 1°³·ë  
±³À°ÁÖÁ¦ : Á¦74Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1)
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190  
À̸ÞÀÏ : urology@urology.or.kr      
±³À°Á¾·ù : ºñ´¢ÀÇÇаú      
Âü¼®¿¹»óÀοø : 900¸í
Èñ¸ÁÆòÁ¡ : 6Á¡   (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 110,000¿ø      
ºñ°í #»çÀüµî·Ï ±âÁØ Àü¹®ÀÇ: 110,000¿ø Àü°øÀÇ: 77,000¿ø Çлý, ÀÎÅÏ: 55,000¿ø °£È£»ç, ¿¬±¸¿ø: 66,000¿ø Á¦¾àȸ»ç ¹× ÀÇ·á±â±âȸ»ç: 132,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-05 Room C (203) 10:00~10:30 Report of Accredited Urologic-endoscopy Unit  ÇѺ´±Ô(ÆÛÆåÆ®ºñ´¢ÀÇÇаúÀÇ¿ø) 
±³À°½Ã°£ 10-05 Room C (203) 10:30~11:00 Understanding and application of prophylactic antibiotics in urology  ÃÖ¼¼¹Î(°æ»óÀÇ´ë) 
±³À°½Ã°£ 10-05 Room C (203) 11:00~11:30 Current Benign Urology  ½Åµ¿±æ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 10-05 Room C (203) 11:30~12:00 Nursing Law from an Urological Perspective  ¼ÛÇÊÇö(¿µ³²ÀÇ´ë) 
½Ä»ç 10-05  12:00~13:00 Á¡½É½Ä»ç  () 
±³À°½Ã°£ 10-05 Room D (209) 13:00~13:05 DEVELOPMENT OF A DRUG SCREENING MODEL FOR RENAL CELL CARCINOMA THROUGH BIO 3D PRINTER-BASED CANCER-ON-A-CHIP  ÃÖÁß¿ø(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 13:05~13:10 CABOZANTINIB-LOADED BIODEGRADABLE POLY(LACTIC-CO-GLYCOLIC ACID) NANOPARTICLES: A NOVEL ADJUVANT THERAPEUTIC STRATEGY TO INHIBIT POST-NEPHRECTOMY METASTATIC RELAPSE IN HIGH-RISK LOCALIZED AND LOCALLY ADVANCED RENAL CELL CARCINOMA  ÀÌÇý¿ø(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 10-05 Room D (209) 13:10~13:15 TUMOR ASSEMBLOID DERIVED FROM PATIENTS WITH RENAL CELL CARCINOMA FOR PREDICTING THE THERAPEUTIC RESPONSE TO IMMUNE CHECKPOINT INHIBITORS  °­¹Î¿ë(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 13:15~13:20 THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY WITH IMMUNE CHECKPOINT INHIBITOR THERAPIES IN METASTATIC RENAL CELL CARCINOMA  ¹ÚÁö¼ö(±¹¸³¼Ò·Ïµµº´¿ø) 
±³À°½Ã°£ 10-05 Room D (209) 13:20~13:25 EFFICACY OF RECOMBINANT BACILLUS CALMETTE-GUÉRIN CONTAINING DLTA IN IN-VIVO THREE-DIMENSIONAL BIO-PRINTED BLADDER CANCER-ON-A-CHIP AND EX-VIVO ORTHOTOPIC MOUSE MODEL  ÃÖÁß¿ø(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 13:25~13:30 STING AGONIST ENCAPSULATING UREASE-POWERED NANOMOTOR FOR IMMUNOTHERAPY OF BLADDER CANCER  Á¤½Âȯ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 13:30~13:35 THERAPEUTIC TARGET FOR HIF-2¥Á ANTAGONIST-RESISTANT CLEAR CELL RENAL CELL CARCINOMA.  À±¿µÀº(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 13:35~13:40 ADDITION OF ONCOLYTIC VIRUS IS AS EFFECTIVE AS ADDITION OF CYTOREDUCTIVE NEPHRECTOMY TO THE FIRST-LINE TREATMENT OF ANTI-PD-1/ANTI-CTLA-4 ANTIBODIES IN THE MURINE METASTATIC RENAL CELL CARCINOMA MODEL  ¹ÚÁö¼ö(±¹¸³¼Ò·Ïµµº´¿ø) 
±³À°½Ã°£ 10-05 Room D (209) 13:40~13:45 COMPARISON OF THREE-DIMENSIONAL PROSTATE CANCER CELL CULTURE USING HYDROGEL, GENE EXPRESSION AND RESISTANCE TO ANTICANCER DRUG  ¼Û¿øÈÆ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 13:45~13:50 IMMUNE CHECKPOINT MOLECULES-TARGETING RECOMBINANT DENDRITIC CELLS FOR THERAPEUTIC EFFECT ON PROSTATE CANCER  ÃÖ¼¼¿µ(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 13:50~13:55 IRREVERSIBLE ELECTROPORATION WITH HIGH-FREQUENCY PULSED ELECTRIC FIELD IN A BEAGLE PROSTATE MODEL  À̹üÁø(¿ï»êÀÇ´ë) 
Åä·Ð 10-05 Room D (209) 13:55~14:00 Åä·Ð  () 
±³À°½Ã°£ 10-05 Room D (209) 14:00~14:05 ANTIFIBROSIS TREATMENT IMPROVES DETRUSOR OVERACTIVITY AND CHRONIC BLADDER PAIN ASSOCIATED WITH NEURAL REMODELING OF CENTRAL NERVOUS SYSTEM IN A MOUSE MODEL OF INTERSTITIAL CYSTITIS  ±ÇÁعü(´ë±¸ÆÄƼ¸¶º´¿ø) 
±³À°½Ã°£ 10-05 Room D (209) 14:05~14:10 A NOVEL THERAPEUTIC APPROACH: A STUDY ON THE MECHANISM OF BOTULINUM NEUROTOXIN-A TIBIAL NERVE PERINEURAL INJECTION FOR ALLEVIATION OF OVERACTIVE BLADDER SYMPTOMS  ³ªÇö¼®(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 14:10~14:15 OVERACTIVE BLADDER MEDICATION, HOW LONG SHOULD IT BE SUSTAINED? MIRABEGRON INTERFERES THE CENTRAL SENSITIZATION INDUCED BY THE MICE MODEL OF OVERACTIVE BLADDER  ±ÇÁعü(´ë±¸ÆÄƼ¸¶º´¿ø) 
±³À°½Ã°£ 10-05 Room D (209) 14:15~14:20 THERAPEUTIC EFFECTS OF AXITINIB, AN ANTI-ANGIOGENIC TYROSINE KINASE INHIBITOR FOR TARGETING INTERSTITIAL CYSTITIS  ½ÅÁ¤Çö(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 14:20~14:25 OVEREXPRESSION OF TRANSIENT RECEPTOR POTENTIAL VANILLOID-4 (TRPV4) IN UROTHELIUM OF RAT URINARY BLADDER FOLLOWING BLADDER OUTLET OBSTRUCTION  ±¸Èñ¸ð(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 14:25~14:30 ANTI-ONCOGENIC EFFECTS OF DUTASTERIDE, A DUAL 5-ALPHA REDUCTASE INHIBITOR, IN BLADDER CANCER  ±è¾Æ¶÷(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 14:30~14:35 INVESTIGATION ON THE EFFECTS OF THE COVID-19 IN URINARY AND STOOL MICROBIOME WITH THE ASSOCIATION OF PROGRESSION OF BENIGN PROSTATIC HYPERPLASIA  ¹ÚÁö¼ö(±¹¸³¼Ò·Ïµµº´¿ø) 
±³À°½Ã°£ 10-05 Room D (209) 14:35~14:40 A PRELIMINARY STUDY FOR IDENTIFYING CORRELATION POLYSTYRENE MICROPLASTICS WITH SPERM QUALITY IN THE MOUSE.  Å¹ü½Ä(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 14:40~14:45 THE EFFICACY AND SAFETY OF A HUMAN PERIRENAL ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION IN AN INTERSTITIAL CYSTITIS RAT MODEL  ÇÏÁö¿ë(°è¸íÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 14:45~14:50 PREVENTION OF URETHRAL FIBROSIS INDUCED BY TRANSFORMING GROWTH FACTOR BETA 1 USING SELECTIVE WNT/¥Â-CATENIN SIGNALING INHIBITORS IN A RAT MODEL  À̽·Ä(Â÷ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 14:50~14:55 METFORMIN AND SILDENAFIL PRESERVE AGAINST ISCHEMIA/REPERFUSION-INDUCED INJURY IN RAT URINARY BLADDERS  ÀÌÀç±Ù(Ãæ³²ÀÇ´ë) 
Åä·Ð 10-05 Room D (209) 14:55~15:00 Åä·Ð  () 
±³À°½Ã°£ 10-05 Room D (209) 15:00~15:05 THE EFFICACY AND SAFETY OF RADIATION-FREE RETROGRADE INTRARENAL SURGERY: A PROSPECTIVE MULTICENTER-BASED RANDOMIZED CONTROLLED STUDY  °­Áر¸(°æºÏÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 15:05~15:10 STONE-FREE RATE OF ECIRS, PCNL, MINIPCNL AND SWL: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS  ÀÌÁÖ¿ë(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 15:10~15:15 A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS ON STONE-FREE RATE OF MINIMAL INVASIVE INTERVENTIONAL THERAPY FOR RENAL STONES INCLUDING UMP, MINIPCNL, MICROPCNL, RIRS AND SWL  ÀÌÁÖ¿ë(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 15:15~15:20 SILODOSIN VERSUS TAMSULOSIN FOR MEDICAL EXPULSIVE THERAPY OF URETERAL STONES: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS  ÀÌÁÖ¿ë(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 15:20~15:25 IS ULTRASONOGRAPHY FOR UROLITHIASIS ACCURATE ENOUGH FOR CLINICAL MANAGEMENT DECISION MAKING?  Yen-Cheng Pan(Launceston General Hospital) 
±³À°½Ã°£ 10-05 Room D (209) 15:25~15:30 COMPARISON OF UROLITHIASIS CT WITH CLARI CT APPLIED TO FILTERED BACK PROJECTION (FBP), STATISTICAL ITERATIVE RECONSTRUCTION (IR), KNOWLEDGE-BASED ITERATIVE MODEL RECONSTRUCTION (IMR) : A PHYSICAL HUMAN PHANTOM STUDY  ½ÉÀçÇå(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 15:30~15:35 DEVELOPMENT OF S.T.O.N.E.S. (STONE SIZE, TOPOGRAPHY, OBESITY, NUMBER OF STONES, EXPOSURE, SKIN TO STONE DISTANCE) NEPHROLITHOMETRY SCORING IN PREDICTING THE STONE FREE RATE OF EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY IN UNCOMPLICATED RENAL STONES  Eduardo Añonuevo(Victoriano Luna Medical Center) 
±³À°½Ã°£ 10-05 Room D (209) 15:35~15:40 COMPARISON OF MINI-PERCUTANEOUS NEPHROLITHOTOMY AND RETROGRADE INTRARENAL SURGERY WITH 1-2CM SIZED RENAL STONES  ¹®Çü¿ì(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 15:40~15:45 COMPARISON BETWEEN MULTISESSION RETROGRADE INTRARENAL SURGERY AND PERCUTANEOUS NEPHROLITHOTOMY FOR RENAL STONES > 3CM  ½ÅÁ¤Çö(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 15:45~15:50 CAN URINARY STONES PHANTOM BE USED AS AN ARTIFICIAL SUBSTITUTE FOR RESEARCH?  Matthew Chau(Royal Perth Hospital) 
±³À°½Ã°£ 10-05 Room D (209) 15:50~15:55 BETTER TARGETING STRATEGIES DURING LITHOTRIPSY BY IN VITRO AND IN VIVO STUDY CONSIDERING RESPIRATION REGULARITY  ±è½ÃÇö(¼­¿ïÀÇ´ë) 
Åä·Ð 10-05 Room D (209) 15:55~16:00 Åä·Ð  () 
±³À°½Ã°£ 10-05 Room D (209) 16:00~16:05 GERMLINE DNA-REPAIR GENES AND HOXB13 MUTATIONS IN KOREAN MEN WITH METASTATIC PROSTATE CANCER : DATA FROM A LARGE KOREAN COHORT  ¼Û»óÇå(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 16:05~16:10 METASTASIS-PRONE GENES REVEALED BY TARGETED SEQUENCING IN PROSTATE CANCER  Á¤½Âȯ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 16:10~16:15 PREVALENCE OF BRCA1 AND BRCA2 GENETIC ALTERATIONS IN KOREAN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER - A SINGLE CENTER DATA OF 51 SAMPLES  ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 16:15~16:20 THE CHANGE OF PROSTATE CANCER RISK-STRATIFICATION IN A SINGLE KOREAN PROVINCE BETWEEN 2003 – 2021: A MULTICENTER STUDY RECRUITING ENTIRE REGIONAL TRAINING HOSPITAL DATA  °í¿µÈÖ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 16:20~16:25 CHARACTERIZATION AND DIAGNOSTIC PERFORMANCE OF URINARY MICROBIOME IN PROSTATE CANCER  ¾ÈÇö±Ô(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 16:25~16:30 CHROMOSOMAL INSTABILITY IN CELL-FREE DNA AS A PROGNOSTIC BIOMARKER OF METASTATIC HORMONE-SENSITIVE PROSTATE CANCER TREATED WITH ANDROGEN DEPRIVATION THERAPY  ÀÌÃæ¾ð(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 16:30~16:35 ETHNIC-SPECIFIC POLYGENIC RISK SCORE FOR TUMOR AGGRESSIVENESS AND EARLY-ONSET PROSTATE CANCER IN ASIANS  ¼Û»óÇå(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 16:35~16:40 EXPLANABLE MACHINE LEARNING MODELS FOR A DEEPER INSIGHT ON TREATMENT DECISION FOR LOCALIZED PROSTATE CANCER  ÇÑÀåÈñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 16:40~16:45 PROGNOSTIC VALUE OF PROSTATE-SPECIFIC ANTIGEN KINETICS DURING TREATMENT OF ADVANCED PROSTATE CANCER WITH ABIRATERONE AND ENZALUTAMIDE: MULTICENTER ANALYSIS  °­º´Áø(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 16:45~16:50 DISCOVERY OF PREDICTIVE MARKER FOR GOOD RESPONSE TO ENZALUTAMIDE IN METASTATIC CRPC: BASED ON MULTICENTER REAL-WORLD DATA  ÇÑÀåÈñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-05 Room D (209) 16:50~16:55 A NOMOGRAM FOR PREDICTION OF PROSTATE CANCER USING PROSTATE HEALTH INDEX IN KOREANS, PROSPECTIVE, MULTI-CENTER STUDY  Á¤ÀçÈÆ(¼º±Õ°üÀÇ´ë) 
Åä·Ð 10-05 Room D (209) 16:55~17:00 Åä·Ð  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦74Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1) : 2022-10-05""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À°(¾ß°£ ±³À°) : 2022-10-05
´ÙÀ½±Û 2022³â Á¦10ȸ ºÎ¿ï°æ³»ºÐºñÇÐȸ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2022-10-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 51 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 36 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 38 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 50 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 40 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 35 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 13 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 13 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 32 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 16 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 14 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 34 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 26 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 30 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 23 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷